top of page


NEWS & PUBLICATIONS
LATEST NEWS

Inhalable dry powder mRNA vaccines based on extracellular vesicles
Respiratory diseases are a global burden, with millions of deaths attributed to pulmonary illnesses and dysfunctions. Therapeutics have...

Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain
The first two vaccines against infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that were approved by regulators...

Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung
Idiopathic pulmonary fibrosis (IPF) is a fatal and incurable form of interstitial lung disease in which persistent injury results in scar...

Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a fatal and incurable form of interstitial lung disease in which persistent injury results in scar...

Cell-mimicking nanodecoys neutralize SARS-CoV-2 & mitigate lung injury in primate model of COVID-19
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has grown into a global...

Exosome Therapeutics for Lung Regenerative Medicine
Exosomes are a type of extracellular vesicle (EV) whose diameter ranges from 30 to 100 nm and are characterized by a cup-shaped...
bottom of page